Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis.
McCloskey, A G
Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis. [electronic resource] - European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences Jan 2020 - 105104 p. digital
Publication Type: Journal Article
1879-0720
10.1016/j.ejps.2019.105104 doi
Aniline Compounds--pharmacology
Animals
Blood Glucose--drug effects
Diabetes Mellitus, Experimental--drug therapy
Diabetes Mellitus, Type 2--drug therapy
Enteroendocrine Cells--drug effects
Glucagon-Like Peptide 1--metabolism
Glucose--metabolism
Homeostasis--drug effects
Hypoglycemic Agents--pharmacology
Insulin--metabolism
Insulin-Secreting Cells--drug effects
Male
Mice
Receptors, G-Protein-Coupled--agonists
Sulfonamides--pharmacology
Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis. [electronic resource] - European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences Jan 2020 - 105104 p. digital
Publication Type: Journal Article
1879-0720
10.1016/j.ejps.2019.105104 doi
Aniline Compounds--pharmacology
Animals
Blood Glucose--drug effects
Diabetes Mellitus, Experimental--drug therapy
Diabetes Mellitus, Type 2--drug therapy
Enteroendocrine Cells--drug effects
Glucagon-Like Peptide 1--metabolism
Glucose--metabolism
Homeostasis--drug effects
Hypoglycemic Agents--pharmacology
Insulin--metabolism
Insulin-Secreting Cells--drug effects
Male
Mice
Receptors, G-Protein-Coupled--agonists
Sulfonamides--pharmacology